XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2022   25,275,369        
Beginning balance at Dec. 31, 2022 $ 646,663 $ 25,275 $ 558,833 $ 252,623 $ (148,957) $ (41,111)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022           (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 16,271     16,271    
Other comprehensive income (loss) 18,183       18,183  
Dividends on common stock (6,498)     (6,498)    
Issuance of common shares for HSBI acquisition (in shares)   6,920,422        
Issuance of common shares for HSBI acquisition 221,522 $ 6,920 214,602      
Issuance of restricted stock grants (in shares)   118,689        
Issuance of restricted stock grants 0 $ 119 (119)      
Restricted stock grants forfeited (in shares)   (500)        
Restricted stock grants forfeited 0 $ (1) 1      
Repurchase of restricted stock for payment of taxes (in shares)   (9,827)        
Repurchase of restricted stock for payment of taxes (307) $ (9) (298)      
Compensation expense 593   593      
Ending balance (in shares) at Mar. 31, 2023   32,304,153        
Ending balance at Mar. 31, 2023 896,427 $ 32,304 773,612 262,396 (130,774) $ (41,111)
Treasury stock, ending balance (in shares) at Mar. 31, 2023           (1,249,607)
Beginning balance (in shares) at Dec. 31, 2022   25,275,369        
Beginning balance at Dec. 31, 2022 646,663 $ 25,275 558,833 252,623 (148,957) $ (41,111)
Treasury stock, beginning balance (in shares) at Dec. 31, 2022           (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 64,410          
Other comprehensive income (loss) (16,211)          
Ending balance (in shares) at Sep. 30, 2023   32,343,411        
Ending balance at Sep. 30, 2023 897,221 $ 32,343 774,598 296,559 (165,168) $ (41,111)
Treasury stock, ending balance (in shares) at Sep. 30, 2023           (1,249,607)
Beginning balance (in shares) at Mar. 31, 2023   32,304,153        
Beginning balance at Mar. 31, 2023 896,427 $ 32,304 773,612 262,396 (130,774) $ (41,111)
Treasury stock, beginning balance (in shares) at Mar. 31, 2023           (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 23,779     23,779    
Other comprehensive income (loss) (14,465)       (14,465)  
Dividends on common stock (6,825)     (6,825)    
Issuance of restricted stock grants (in shares)   45,773        
Issuance of restricted stock grants 0 $ 46 (46)      
Restricted stock grants forfeited (in shares)   (4,526)        
Restricted stock grants forfeited 0 $ (5) 5      
Compensation expense 530   530      
Ending balance (in shares) at Jun. 30, 2023   32,345,400        
Ending balance at Jun. 30, 2023 899,446 $ 32,345 774,101 279,350 (145,239) $ (41,111)
Treasury stock, ending balance (in shares) at Jun. 30, 2023           (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 24,360     24,360    
Other comprehensive income (loss) (19,929)       (19,929)  
Dividends on common stock (7,151)     (7,151)    
Issuance of restricted stock grants (in shares)   2,711        
Issuance of restricted stock grants 0 $ 3 (3)      
Restricted stock grants forfeited (in shares)   (3,596)        
Restricted stock grants forfeited 0 $ (4) 4      
Repurchase of restricted stock for payment of taxes (in shares)   (1,104)        
Repurchase of restricted stock for payment of taxes (32) $ (1) (31)      
Compensation expense 527   527      
Ending balance (in shares) at Sep. 30, 2023   32,343,411        
Ending balance at Sep. 30, 2023 897,221 $ 32,343 774,598 296,559 (165,168) $ (41,111)
Treasury stock, ending balance (in shares) at Sep. 30, 2023           (1,249,607)
Beginning balance (in shares) at Dec. 31, 2023   32,338,983        
Beginning balance at Dec. 31, 2023 $ 949,034 $ 32,339 775,232 300,150 (117,576) $ (41,111)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 (1,249,607)         (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 20,628     20,628    
Other comprehensive income (loss) (2,312)       (2,312)  
Dividends on common stock (7,777)     (7,777)    
Issuance of restricted stock grants (in shares)   141,457        
Issuance of restricted stock grants 0 $ 141 (141)      
Repurchase of restricted stock for payment of taxes (in shares)   (12,512)        
Repurchase of restricted stock for payment of taxes (314) $ (12) (302)      
Compensation expense 653   653      
Ending balance (in shares) at Mar. 31, 2024   32,467,928        
Ending balance at Mar. 31, 2024 959,912 $ 32,468 775,442 313,001 (119,888) $ (41,111)
Treasury stock, ending balance (in shares) at Mar. 31, 2024           (1,249,607)
Beginning balance (in shares) at Dec. 31, 2023   32,338,983        
Beginning balance at Dec. 31, 2023 $ 949,034 $ 32,339 775,232 300,150 (117,576) $ (41,111)
Treasury stock, beginning balance (in shares) at Dec. 31, 2023 (1,249,607)         (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 58,896          
Other comprehensive income (loss) 25,500          
Ending balance (in shares) at Sep. 30, 2024   32,450,440        
Ending balance at Sep. 30, 2024 $ 1,011,683 $ 32,450 776,731 335,689 (92,076) $ (41,111)
Treasury stock, ending balance (in shares) at Sep. 30, 2024 (1,249,607)         (1,249,607)
Beginning balance (in shares) at Mar. 31, 2024   32,467,928        
Beginning balance at Mar. 31, 2024 $ 959,912 $ 32,468 775,442 313,001 (119,888) $ (41,111)
Treasury stock, beginning balance (in shares) at Mar. 31, 2024           (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 19,697     19,697    
Other comprehensive income (loss) (577)       (577)  
Dividends on common stock (7,799)     (7,799)    
Issuance of restricted stock grants (in shares)   2,847        
Issuance of restricted stock grants 0 $ 3 (3)      
Restricted stock grants forfeited (in shares)   (5,768)        
Restricted stock grants forfeited 0 $ (6) 6      
Repurchase of restricted stock for payment of taxes (in shares)   (595)        
Repurchase of restricted stock for payment of taxes (15) $ (1) (14)      
Compensation expense 667   667      
Ending balance (in shares) at Jun. 30, 2024   32,464,412        
Ending balance at Jun. 30, 2024 971,885 $ 32,464 776,098 324,899 (120,465) $ (41,111)
Treasury stock, ending balance (in shares) at Jun. 30, 2024           (1,249,607)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 18,571     18,571    
Other comprehensive income (loss) 28,389       28,389  
Dividends on common stock (7,781)     (7,781)    
Issuance of restricted stock grants (in shares)   2,800        
Issuance of restricted stock grants 0 $ 3 (3)      
Restricted stock grants forfeited (in shares)   (14,903)        
Restricted stock grants forfeited 0 $ (15) 15      
Repurchase of restricted stock for payment of taxes (in shares)   (1,869)        
Repurchase of restricted stock for payment of taxes (55) $ (2) (53)      
Compensation expense 674   674      
Ending balance (in shares) at Sep. 30, 2024   32,450,440        
Ending balance at Sep. 30, 2024 $ 1,011,683 $ 32,450 $ 776,731 $ 335,689 $ (92,076) $ (41,111)
Treasury stock, ending balance (in shares) at Sep. 30, 2024 (1,249,607)         (1,249,607)